{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:10:17Z","timestamp":1772129417132,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001588","name":"Enterprise Ireland","doi-asserted-by":"publisher","award":["IP\/2022\/1011"],"award-info":[{"award-number":["IP\/2022\/1011"]}],"id":[{"id":"10.13039\/501100001588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbiotec.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:10:38Z","timestamp":1758575438000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reduction of high mannose glycoforms from monoclonal antibodies by affinity chromatography using a recombinant prokaryotic lectin"],"prefix":"10.1016","volume":"408","author":[{"given":"Elizabeth","family":"Matthews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9463-7698","authenticated-orcid":false,"given":"Neha Tushar","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2025.09.008_bib1","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.jmb.2014.07.006","article-title":"Structural characterization of anti-inflammatory immunoglobulin g fc proteins","volume":"426","author":"Ahmed","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1749-6632.2011.06305.x","article-title":"Novel roles for the IgG fc glycan","volume":"1253","author":"Anthony","year":"2012","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/btpr.2366","article-title":"Glycosylation of monoclonal antibody products: current status and future prospects","volume":"32","author":"Batra","year":"2016","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bp00031a001","article-title":"In pursuit of the optimal fed-batch process for monoclonal antibody production","volume":"11","author":"Bibila","year":"1995","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/antib9020022","article-title":"Principles of N-Linked glycosylation variations of IgG-Based therapeutics: pharmacokinetic and functional considerations","volume":"9","author":"Boune","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3076","article-title":"A class of low-cost alternatives to kifunensine for increasing high mannose N-linked glycosylation for monoclonal antibody production in Chinese hamster ovary cells","volume":"37","author":"Brantley","year":"2021","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chroma.2007.06.012","article-title":"Fragments of protein a eluted during protein a affinity chromatography","volume":"1163","author":"Carter-Franklin","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.70024","article-title":"N-acetyl-D-mannosamine, a novel additive, effectively reducing high mannose glycosylation of monoclonal antibody without affecting other quality attributes","author":"Chai","year":"2025","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19","volume":"384","author":"Chen","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/cancers13020312","article-title":"Engineering Anti-Tumor monoclonal antibodies and fc receptors to enhance ADCC by human NK cells","volume":"13","author":"Dixon","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2019.08.044","article-title":"Glycosylation of biosimilars: recent advances in analytical characterization and clinical implications","volume":"1089","author":"Duivelshof","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/bit.28066","article-title":"Strategies to control therapeutic antibody glycosylation during bioprocessing: synthesis and separation","volume":"119","author":"Edwards","year":"2022","journal-title":"Biotech. Bioeng."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib13","series-title":"ICH Quality Guidelines","first-page":"433","article-title":"ICH Q6A specifications: Test procedures and acceptance criteria for new drug dubstances and new drug products: Chemical substance","author":"Elder","year":"2017"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jprot.2008.06.011","article-title":"Affinity separation and enrichment methods in proteomic analysis","volume":"71","author":"Fang","year":"2008","journal-title":"J. Proteom."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338352","article-title":"Tailor-made recombinant prokaryotic lectins for characterisation of glycoproteins","volume":"1155","author":"Fernandez-Poza","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib16","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.molimm.2010.04.006","article-title":"Naturally occurring glycan forms of human immunoglobulins G1 and G2","volume":"47","author":"Flynn","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/glycob\/cwr027","article-title":"High-mannose glycans on the fc region of therapeutic IgG antibodies increase serum clearance in humans","volume":"21","author":"Goetze","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708227","article-title":"To bnab or not to bnab: defining broadly neutralising antibodies against HIV-1","volume":"12","author":"Griffith","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11051-022-05594-1","article-title":"Applications of mannose-binding lectins and mannan glycoconjugates in nanomedicine","volume":"24","author":"Gupta","year":"2022","journal-title":"J. Nanopart. Res"},{"issue":"24","key":"10.1016\/j.jbiotec.2025.09.008_bib20","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1007\/s00253-018-9430-6","article-title":"Glycosylation control technologies for recombinant therapeutic proteins","volume":"102","author":"Gupta","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/biot.201100015","article-title":"Isolation and purification of recombinant proteins, antibodies and plasmid DNA with hydroxyapatite chromatography","volume":"7","author":"Hilbrig","year":"2012","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/bit.25534","article-title":"A robust method for increasing fc glycan high mannose level of recombinant antibodies","volume":"112","author":"Huang","year":"2015","journal-title":"Biotech. Bioeng."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1803645","article-title":"Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to A\u03b2 aggregates","volume":"12","author":"Kwiatkowski","year":"2020","journal-title":"mAbs"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00145","article-title":"Glycans \u00e2\u20ac\u201c the third revolution in evolution","volume":"5","author":"Lauc","year":"2014","journal-title":"Front. Genet"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jbiotec.2013.11.007","article-title":"The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody","volume":"170","author":"Liu","year":"2014","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102420","article-title":"Recent advances in antibody glycoengineering for the gain of functions","volume":"78","author":"Liu","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11095-023-03628-4","article-title":"Benchmark glycan profile of therapeutic monoclonal antibodies produced by mammalian cell expression systems","volume":"41","author":"Luo","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib28","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.tibtech.2020.05.009","article-title":"The formidable challenge of controlling high Mannose-Type N-Glycans in therapeutic mabs","volume":"38","author":"Mastrangeli","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib29","unstructured":"Mikulic, M., 2024. Biophramaceuticals market size worldwide forecast 2022-2032."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0161-5890(00)00105-X","article-title":"The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms","volume":"37","author":"Mimura","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-0716-1685-7_6","article-title":"Cell free remodeling of glycosylation of antibodies","volume":"2370","author":"Mota","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107552","article-title":"Mammalian cell culture for production of recombinant proteins: a review of the critical steps in their biomanufacturing","volume":"43","author":"O\u2019Flaherty","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/07388551.2012.670614","article-title":"Recombinant lectins: an array of tailor-made glycan-interaction biosynthetic tools","volume":"33","author":"Oliveira","year":"2013","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib34","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/jssc.201200434","article-title":"Glycopeptide enrichment and separation for protein glycosylation analysis","volume":"35","author":"Ongay","year":"2012","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s42003-023-04937-5","article-title":"Production of recombinant human IgG1 fc with beneficial N-glycosylation pattern for anti-inflammatory activity using genome-edited chickens","volume":"6","author":"Park","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00216-021-03648-2","article-title":"Monitoring process-related impurities in biologics\u2013host cell protein analysis","volume":"414","author":"Pilely","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700216","article-title":"Using titer and titer normalized to confluence are complementary strategies for obtaining Chinese hamster ovary cell lines with high volumetric productivity of etanercept","volume":"13","author":"Pristov\u0161ek","year":"2018","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3176","article-title":"Modulation of high mannose levels in n -linked glycosylation through cell culture process conditions to increase antibody-dependent cell-mediated cytotoxicity activity for an antibody biosimilar","volume":"37","author":"Rameez","year":"2021","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib39","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/bit.25318","article-title":"Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans","volume":"111","author":"Shi","year":"2014","journal-title":"Biotech. Bioeng."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib40","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1007\/s00216-024-05261-5","article-title":"Assessment of monoclonal antibody glycosylation: a comparative study using HRMS NMR, and HILIC-FLD","volume":"416","author":"Shipman","year":"2024","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib41","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/btpr.50","article-title":"Host cell protein clearance during protein a chromatography: development of an improved column wash step","volume":"24","author":"Shukla","year":"2008","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biologicals.2019.01.002","article-title":"Control of therapeutic IgG antibodies galactosylation during cultivation process and its impact on IgG1\/Fc\u03b3R interaction and ADCC activity","volume":"58","author":"Simonov","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib43","series-title":"Animal Cell Culture","first-page":"237","article-title":"Glycosylation in cell culture","author":"Spearman","year":"2015"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700381","article-title":"Solid-Phase enzymatic remodeling produces high yields of single glycoform antibodies","volume":"13","author":"Tayi","year":"2018","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib45","unstructured":"Tayi, V.S., Butler, M., 2019. Methods to produce single glycoform monoclonal antibodies. EP3108004A1."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib46","unstructured":"Tayi, V.S., Butler, M., 2023. Methods to produce single glycoform monoclonal antibodies. US11821017B2."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10719-020-09942-y","article-title":"130 years of plant lectin research","volume":"37","author":"Tsaneva","year":"2020","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/19420862.2018.1551044","article-title":"Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms","volume":"11","author":"Wada","year":"2019","journal-title":"mAbs"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib49","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","article-title":"Biopharmaceutical benchmarks 2022","volume":"40","author":"Walsh","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib50","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/cpt.2783","article-title":"The mannose in the mirror: a reflection on the pharmacokinetic impact of high mannose glycans of monoclonal antibodies in biosimilar development","volume":"113","author":"Welch","year":"2023","journal-title":"Clin. Pharma Ther."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.70036","article-title":"Enhanced cell-specific productivity through delayed supplementation of antioxidants in intensified processes","author":"Wu","year":"2025","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114205","article-title":"High-throughput and high-sensitivity N-Glycan profiling: a platform for biopharmaceutical development and disease biomarker discovery","volume":"623","author":"Xie","year":"2021","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib53","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00253-022-12342-x","article-title":"Progress in fed-batch culture for recombinant protein production in CHO cells","volume":"107","author":"Xu","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/antib9030034","article-title":"Monoclonal antibodies in cancer therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.jbiotec.2025.09.008_bib55","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1007\/s00253-016-7380-4","article-title":"A control strategy to investigate the relationship between specific productivity and high-mannose glycoforms in CHO cells","volume":"100","author":"Zalai","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.copbio.2021.12.008","article-title":"Recent advances in synthetic glycoengineering for biological applications","volume":"74","author":"Zeng","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jbiotec.2025.09.008_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pep.2008.10.011","article-title":"Transient expression and purification of chimeric heavy chain antibodies","volume":"65","author":"Zhang","year":"2009","journal-title":"Protein Expr. Purif."}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165625002354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165625002354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:58:58Z","timestamp":1762257538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165625002354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0168165625002354"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2025.09.008","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of high mannose glycoforms from monoclonal antibodies by affinity chromatography using a recombinant prokaryotic lectin","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}